RIFAMPICIN-RESISTANT TUBERCULOSIS
Clinical trials for RIFAMPICIN-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new RIFAMPICIN-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for RIFAMPICIN-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Drug-Resistant TB: experimental combo trial launches
Disease control Recruiting nowThis study tests a new drug called JDB0131, combined with other TB medications, in 60 people with rifampin-resistant tuberculosis. Participants will receive one of two doses of JDB0131 or a standard drug (delamanid) for 8 weeks. The goal is to see which combination clears the bac…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: PHASE2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could nurses replace doctors for TB treatment? major trial underway
Disease control Recruiting nowThis study compares nurse-led treatment for drug-resistant tuberculosis (TB) in local clinics to standard doctor-led care in hospitals. About 2,944 people will take part across South Africa. The goal is to see if nurse-led care works just as well, is safe, and lowers costs for pa…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Massive global study aims to slash TB deaths with smarter testing
Diagnosis Recruiting nowThis study aims to find faster, simpler, and cheaper ways to diagnose tuberculosis (TB), a disease that kills over a million people each year. Researchers will test new diagnostic tools on over 26,000 adults in 10 countries who have a cough lasting two weeks or more, or who have …
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC